Composition and methods for treatment of hyperplasia
Details for Australian Patent Application No. 2002303626 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 09/847,945 02.05.01 US
17 April 2003 Application Open to Public Inspection
Published as AU-B-2002303626
24 April 2008 Assignment before Grant
American Bioscience, Inc. The application has been assigned to Abraxis BioScience, LLC
24 April 2008 Application Accepted
Published as AU-B-2002303626
21 August 2008 Standard Patent Sealed
15 January 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 24 Oct 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
11 June 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 24 Oct 2008
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002303627-TRANSMITTING FORWARD LINK ASSIGNMENTS TO A MOBILE PLATFORM
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser